 Connection
John Messenger to Thrombosis
This is a "connection" page, showing publications John Messenger has written about Thrombosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.179 |
|
|
|
-
White DC, Grines CL, Grines LL, Marcovitz P, Messenger J, Schreiber T. Comparison of the usefulness of enoxaparin versus warfarin for prevention of left ventricular mural thrombus after anterior wall acute myocardial infarction. Am J Cardiol. 2015 May 01; 115(9):1200-3.
Score: 0.098
-
Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006 Jun 20; 113(24):2803-9.
Score: 0.054
-
Rymer JA, Harrison RW, Dai D, Roe MT, Messenger JC, Anderson HV, Peterson ED, Wang TY. Trends in Bare-Metal Stent Use in the United States in Patients Aged =65?Years (from the CathPCI Registry). Am J Cardiol. 2016 10 01; 118(7):959-66.
Score: 0.027
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|